uracil has been researched along with Cytomegalovirus in 12 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Cytomegalovirus: A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Here, we report the molecular characterization of the human cytomegalovirus uracil DNA glycosylase (UNG) UL114." | 7.74 | Characterization of human cytomegalovirus uracil DNA glycosylase (UL114) and its interaction with polymerase processivity factor (UL44). ( Bjørås, M; Dale, HA; Luna, L; Ranneberg-Nilsen, T; Rollag, H; Slettebakk, R; Sundheim, O, 2008) |
| " Herein we report the design, synthesis and antiviral evaluation of a new family of non-nucleoside antivirals, derived from 1-[ω-(4-bromophenoxy)alkyl]uracil derivatives--previously reported inhibitors of human cytomegalovirus (HCMV)." | 3.81 | Toward the discovery of dual HCMV-VZV inhibitors: Synthesis, structure activity relationship analysis, and cytotoxicity studies of long chained 2-uracil-3-yl-N-(4-phenoxyphenyl)acetamides. ( Andrei, G; Babkov, DA; Chizhov, AO; Khandazhinskaya, AL; Novikov, MS; Seley-Radtke, KL; Snoeck, R, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Paramonova, MP | 3 |
| Gureeva, ES | 2 |
| Ozerov, AA | 3 |
| Snoeck, R | 5 |
| Andrei, G | 7 |
| Alexandrov, DA | 1 |
| Handazinskaya, AL | 1 |
| Novikov, MS | 4 |
| Kochetkov, SN | 2 |
| Aleksandrov, DA | 1 |
| Khandazhinskaya, AL | 3 |
| Nishio-Nagai, M | 1 |
| Suzuki, S | 1 |
| Yoshikawa, K | 1 |
| Ueda, R | 1 |
| Kazaoka, Y | 1 |
| Roche, KL | 1 |
| Nukui, M | 1 |
| Krishna, BA | 1 |
| O'Connor, CM | 1 |
| Murphy, EA | 1 |
| Babkov, DA | 2 |
| Chizhov, AO | 2 |
| Balzarini, J | 4 |
| Seley-Radtke, KL | 2 |
| Ranneberg-Nilsen, T | 2 |
| Dale, HA | 2 |
| Luna, L | 2 |
| Slettebakk, R | 2 |
| Sundheim, O | 1 |
| Rollag, H | 2 |
| Bjørås, M | 2 |
| Maruyama, T | 3 |
| Kozai, S | 3 |
| Yamasaki, T | 1 |
| Witvrouw, M | 3 |
| Pannecouque, C | 3 |
| De Clercq, E | 3 |
| Seeberg, E | 1 |
| Demizu, Y | 2 |
| Snoecks, R | 2 |
| Slusarchyk, WA | 1 |
| Bisacchi, GS | 1 |
| Field, AK | 1 |
| Hockstein, DR | 1 |
| Jacobs, GA | 1 |
| McGeever-Rubin, B | 1 |
| Tino, JA | 1 |
| Tuomari, AV | 1 |
| Yamanaka, GA | 1 |
| Young, MG | 1 |
12 other studies available for uracil and Cytomegalovirus
| Article | Year |
|---|---|
Synthesis of 1-[ω-(Bromophenoxy)alkyl]-3-Naphthalenylmethyl Uracil Derivatives and Their Analogues as Probable Inhibitors of Human Cytomegalovirus Replication.
Topics: Antiviral Agents; Cytomegalovirus; Humans; Structure-Activity Relationship; Uracil | 2022 |
Synthesis of 1-[ω-(Bromophenoxy)alkyl]-3-naphthalenylmethyl Derivatives of Uracil and Their Analogues As Probable Inhibitors of Human Cytomegalovirus Replication.
Topics: Antiviral Agents; Cytomegalovirus; Humans; Structure-Activity Relationship; Uracil | 2023 |
Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Prolifera | 2017 |
Selective 4-Thiouracil Labeling of RNA Transcripts within Latently Infected Cells after Infection with Human Cytomegalovirus Expressing Functional Uracil Phosphoribosyltransferase.
Topics: Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Humans; Pentosyltransferases; RNA, Vir | 2018 |
Synthesis and anti-HCMV activity of 1-[ω-(phenoxy)alkyl]uracil derivatives and analogues thereof.
Topics: Antiviral Agents; Cells, Cultured; Cytomegalovirus; Humans; Receptors, Virus; Structure-Activity Rel | 2013 |
Toward the discovery of dual HCMV-VZV inhibitors: Synthesis, structure activity relationship analysis, and cytotoxicity studies of long chained 2-uracil-3-yl-N-(4-phenoxyphenyl)acetamides.
Topics: Acetamides; Antiviral Agents; Cell Line; Cell Proliferation; Cytomegalovirus; DNA Viruses; Drug Eval | 2015 |
Characterization of human cytomegalovirus uracil DNA glycosylase (UL114) and its interaction with polymerase processivity factor (UL44).
Topics: Binding Sites; Cells, Cultured; Cytomegalovirus; DNA; DNA-Binding Proteins; Electrophoresis, Polyacr | 2008 |
Synthesis and antiviral activity of 1,3-disubstituted uracils against HIV-1 and HCMV.
Topics: Antiviral Agents; Cytomegalovirus; HIV-1; Humans; Inhibitory Concentration 50; Microbial Sensitivity | 2003 |
Human cytomegalovirus infection modulates DNA base excision repair in fibroblast cells.
Topics: Base Sequence; Cell Cycle; Cells, Cultured; Cytomegalovirus; DNA Damage; DNA Repair; DNA Replication | 2006 |
Synthesis and anti-HIV-1 and anti-HCMV activity of 1-substituted 3-(3,5-dimethylbenzyl)uracil derivatives.
Topics: Anti-HIV Agents; Cytomegalovirus; HIV Reverse Transcriptase; HIV-1; Indicators and Reagents; Ligands | 2006 |
Antiviral activity of 3-(3,5-dimethylbenzyl)uracil derivatives against HIV-1 and HCMV.
Topics: Adenosine; Antiviral Agents; Cytomegalovirus; HIV-1; Humans; Ribonucleosides; Uracil | 2007 |
Synthesis and antiviral activity of 1-cyclobutyl-5-(2-bromovinyl)uracil nucleoside analogues and related compounds.
Topics: Antiviral Agents; Cells, Cultured; Cyclobutanes; Cytomegalovirus; Herpesvirus 3, Human; Phosphorylat | 1992 |